Beijing Leadman Biochemistry Co (SZSE:300289) Risk Assessment

View and export this data going back to 2012. Start your Free Trial

What is Beijing Leadman Biochemistry Co Risk Assessment?

Risk Assessment represents the investment risk of a stock derived from our exclusive method. It suggests how risky the investment opportunity is based on the valuation and the fundamental performance of the stock. It is derived from following key aspects:

1. GuruFocus internally developed valuations of the stock, such as GF valuation.
2. Quality Rank, a business quality indicator developed by GuruFocus.
3. Fundamental performance: Piotroski F-Score, Altman Z-Score, Beneish M-Score, etc.
4. Growth opportunities: 5-year revenue growth rate, 5-Year EPS without NRI Growth Rate, etc.

Value investors are always willing to find undervalued stocks. However, not all the undervalued stocks are good deals, we should also be careful of how risky the investment opportunity is. We believe that if the company's financial strength and profitability are strong, and the stock price is within a reasonable range of the GF valuation, or stock has a high return with its price being undervalued, then it might be a good investment opportunity with low risk.

Based on those aspects listed above, GuruFocus believes the risk assessment of Beijing Leadman Biochemistry Co is: Moderate Risk: Sensitive, better choose undervalued stock.

Competitive Comparison of Beijing Leadman Biochemistry Co's Risk Assessment

For the Medical Devices subindustry, Beijing Leadman Biochemistry Co's Risk Assessment, along with its competitors' market caps and Risk Assessment data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Beijing Leadman Biochemistry Co's Risk Assessment Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Beijing Leadman Biochemistry Co's Risk Assessment distribution charts can be found below:

* The bar in red indicates where Beijing Leadman Biochemistry Co's Risk Assessment falls into.

Beijing Leadman Biochemistry Co (SZSE:300289) Risk Assessment Explanation

Based on the four aspects listed above, GuruFocus provides the following 7 evaluations:

All-in-One Screener Examples (1)
Low Risk: Strong fundamentals, worth long-term holding
Moderate Risk: Sensitive, better choose undervalued stock
High Risk: High uncertainty with risk-return tradeoff
High Risk: Good fundamentals, beware of shrinking business
High Risk: Sensitive to economic or industry trends
High Risk: High uncertainty
No Data: Cannot be evaluated

(1) These are some simple examples. You can access our Risk Assessment filter under All-in-One Screener’s Fundamental tab and set your own criteria.

Beijing Leadman Biochemistry Co Risk Assessment Related Terms

Thank you for viewing the detailed overview of Beijing Leadman Biochemistry Co's Risk Assessment provided by GuruFocus.com. Please click on the following links to see related term pages.

Beijing Leadman Biochemistry Co (SZSE:300289) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Beijing Leadman Biochemistry Co Ltd (SZSE:300289) » Definitions » Risk Assessment

Comparable Companies

Traded in Other Exchanges

N/A

Address

No.5 Hongda South Road, Beijing, CHN

Website

http://www.leadmanbio.com

Beijing Leadman Biochemistry Co Ltd is a biotechnology company based in China. The company is focusing on research and development, manufacture, and sales of in vitro diagnostic (IVD) products. The company has core competencies in biochemistry, in vitro diagnostic reagents and instruments. Its product offering includes biochemical raw materials such as enzymes, coenzymes, antibodies, buffers, and enzyme substrates; biochemistry diagnostic and companion reagents; and medical test instruments.

Executives

Ding Yao Liang	Executives
Wang Xiao Hong	Supervisors
Zhang Hai Tao	Executives
Zhang Ya Li	Supervisors
Sun Qian	Director
Wang Jian Hua	Directors, executives
Wang Yi Xing	Directors, executives
Yang Lu Ping	Securities Affairs Representative
Niu Ju Hui	Secretary Dong
Zhang Kun	Director
Shen Guang Qian	Directors, executives
Ma Yan Wen	Director
Wang Lan Zhen	Directors, executives

Beijing Leadman Biochemistry Co (SZSE:300289) Headlines

No Headlines